Latent Autoimmune Diabetes of the Adult (LADA): a case report of a misunderstood form of diabetes

Niskanen, 1995, GAD antibodies in NIDDM, Diabetes Care, 12, 1557, 10.2337/diacare.18.12.1557 Zimmet, 1995, The pathogenesis and prevention of diabetes in adults, Diabetes Care, 7, 1050, 10.2337/diacare.18.7.1050 Harris, 1994, Prevalence of adult-onset IDDM in the U.S. population, Diabetes Care, 11, 1337, 10.2337/diacare.17.11.1337 LinksStenström, 2005, Latent autoimmune diabetes in adults: definition, prevalence, beta-cell function, and treatment, Diabetes, 2, S68, 10.2337/diabetes.54.suppl_2.S68 Carlsson, 2000, Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA), J Clin Endocrinol Metab, 1, 76, 10.1210/jc.85.1.76 Groop, 1986, Islet cell antibodies identify latent type I diabetes in patients aged 35-75 years at diagnosis, Diabetes, 2, 237, 10.2337/diabetes.35.2.237 Fourlanos, 2006, A clinical screening tool identifies autoimmune diabetes in adults, Diabetes Care, 29, 970, 10.2337/dc05-2101 Leslie, 2006, Type 1 diabetes and latent autoimmune diabetes in adults: one end of the rainbow, J Clin Endocrinol Metab, 91, 1654, 10.1210/jc.2005-1623 Kobayashi, 2003, Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes, J Clin Endocrinol Metab, 88, 4768, 10.1210/jc.2002-021529 Falorni, 2000, Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus, J Clin Endocrinol Metab, 1, 309, 10.1210/jc.85.1.309 Maruyama, 2008, Insulin intervention in slowly progressive insulin-dependent (type 1) diabetes mellitus, J Clin Endocrinol Metab, 6, 2115, 10.1210/jc.2007-2267 Rosário, 2005, Comparison of clinical and laboratory characteristics between adult-onset type 1 diabetes and latent autoimmune diabetes in adults, Diabetes Care, 7, 1803, 10.2337/diacare.28.7.1803